Inhibiting B3GALT5 or its biosynthetic products for breast and pancreatic cancers

DISEASE CATEGORY: Cancer

INDICATION: Breast cancer; pancreatic cancer

Patient sample, cell culture and mouse studies suggest inhibiting B3GALT5 or its downstream

Read the full 190 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE